MELAMINE CHEMICALS INC
8-A12G/A, 1997-10-14
INDUSTRIAL INORGANIC CHEMICALS
Previous: AIR METHODS CORP, 8-K/A, 1997-10-14
Next: AMERICA FIRST FINANCIAL FUND 1987-A LIMITED PARTNERSHIP, SC 13D/A, 1997-10-14






                SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549




                            FORM 8-A/A
                        (Amendment No. 3)

        For Registration of Certain Classes of Securities
             Pursuant to Section 12(b) or (g) of the
                 Securities Exchange Act of 1934


                     MELAMINE CHEMICALS, INC.
      (Exact name of registrant as specified in its charter)


             Delaware                                 64-0475913
(State of incorporation or organization)   (IRS EmployerIdentification No.)


                         Highway 18 West
                 Donaldsonville, Louisiana  70346
       (Address of principal executive offices)  (Zip Code)


Securities to be registered pursuant to Section 12(b) of the
Act:

     Title of each class      Name of each exchange on which
     to be so registered      each class is to be registered

     None                          None


Securities to be registered pursuant to Section 12(g) of the
Act:

                 PREFERRED SHARE PURCHASE RIGHTS
                       (Title of Class)



     The  undersigned  registrant  hereby further amends the
following items and exhibits of its  Registration  Statement
on Form 8-A, dated November 9, 1990, as amended by a  Form 8
dated  August  20,  1991  and a Form 8-A/A dated December 8,
1994 (as amended, the "Form  8-A"),  in the manner set forth
below:

Item 1.   Description of Securities To Be Registered.

     On  October  9,  1997,  Melamine Chemicals,  Inc.  (the
"Company") entered into an Agreement  and  Plan of Merger by
and among Borden Chemical, Inc., MC Merger Corp.,  a  wholly
owned   subsidiary   of  Borden  Chemical,  Inc.  (together,
"Borden"), and the Company  (the  "Merger  Agreement").   On
October  9,  1997,  prior  to  the  execution  of the Merger
Agreement,  the  Company  adopted  and  executed  the  Third
Amendment  (the  "Third Amendment") and the Fourth Amendment
(the "Fourth Amendment")  to  the Company's Rights Agreement
dated  November  5,  1990  (the  "Rights   Agreement")  with
Wachovia  Bank  and Trust Company, N.A. (now Wachovia  Bank,
N.A.) as Rights Agent  (the  "Rights  Agent"), as previously
amended by instruments dated as of August 7, 1991 and August
3,  1994.  The description of the Preferred  Share  Purchase
Rights  contained  in  Item  1  of  the Form 8-A is attached
hereto as Exhibit 1 and incorporated herein by reference.

     The  Third  Amendment  amends the Rights  Agreement  by
redefining the "Final Expiration Date" as November 15, 1998.
A copy of the Third Amendment  is attached hereto as Exhibit
6 and incorporated herein by reference.

     The Fourth Amendment amends  the  Rights  Agreement  by
exempting  (1)  the approval, execution, delivery, amendment
or consummation of  any  of the transactions contemplated by
the Merger Agreement, (2)  the public announcement or making
of a tender offer (the "Tender  Offer")  by  Borden  for the
Common Shares of the Company, or the acceptance for purchase
of such shares thereunder, and (3) Borden and its affiliates
and  associates, from the definitions of "Acquiring Person,"
"Beneficial  Owner,"  and "Beneficially Owned" in the Rights
Agreement, and from the  restrictions  imposed by the Rights
Agreement on Acquiring Persons generally;  and providing for
the  Preferred  Share Purchase Rights to expire  immediately
prior to the acceptance  for  purchase  of  shares of Common
Stock by Borden pursuant to the Tender Offer.  A copy of the
Fourth  Amendment  is  attached  hereto  as  Exhibit  6  and
incorporated herein by reference.

Item 2.   Exhibits.

Exhibit   Description
No.

(1)       Item 1 of the Form 8-A.

(2)       Rights  Agreement,  dated as of November  5,  1990
          between the Company and  Wachovia  Bank  and Trust
          Company,   N.A.   as  Rights  Agent  (the  "Rights
          Agreement") (Previously  filed as Exhibit 1 to the
          Form 8-A, and incorporated herein by reference).

(3)       Amendment to the Rights Agreement  dated August 7,
          1991.   (Previously  filed  as  Exhibit  2  to  an
          amendment on Form 8 dated August  20,  1991 to the
          Form 8-A and incorporated herein by reference).

(4)       Second  Amendment  to  the Rights Agreement  dated
          August 3, 1994  (Previously  filed as Exhibit 4 to
          an amendment on Form 8-A/A dated  December 8, 1994
          to  the  Form  8-A  and  incorporated  herein   by
          reference).

(5)       Third  Amendment  to  the  Rights  Agreement dated
          October 9, 1997.

(6)       Fourth  Amendment  to  the Rights Agreement  dated
          October 9, 1997.



                            SIGNATURE

          Pursuant to the requirements  of Section 12 of the
Securities  Exchange  Act of 1934, the registrant  has  duly
caused this amendment to  its registration statement on Form
8-A to be signed on its behalf by the undersigned, thereunto
duly authorized.


Dated:  October 14, 1997


                              MELAMINE CHEMICALS, INC.



                              By:  /s/ Wayne D. DeLeo
                                   ------------------
                                   Wayne D. DeLeo,  
                                   Vice President and
                                   Chief Financial Officer








                                                   Exhibit 1

The  description below is from the Form 8-A, dated  November
9, 1990, as amended by a Form 8, dated August 20, 1991 and a
Form 8-A, dated  December 8, 1994, and does not reflect
the amendments to the Rights  Agreement  effected on October
9, 1997 which are described in the amendment  on  Form 8-A/A
dated October 13, 1997.

Item 1.   Description of Securities To Be Registered.

          On  November  5,  1990, the Board of Directors  of
Melamine Chemicals, Inc. (the "Company") declared a dividend
of one preferred share purchase  right  (a "Right") for each
outstanding share of common stock, par value  $.01 per share
(the  "Common  Shares"),  of the Company.  The dividend  was
paid  on  November  15,  1990 (the  "Record  Date")  to  the
stockholders of record on  that  date.   Each Right entitles
the registered holder to purchase from the  Company one one-
hundredth  of  a  share  of  Series  A  Junior Participating
Preferred Stock, par value $1.00 per share  (the  "Preferred
Shares"),  of the Company at a price of $30.00 per one  one-
hundredth of  a  Preferred  Share  (the  "Purchase  Price"),
subject  to  adjustment.   The description and terms of  the
Rights  are  set forth in a Rights  Agreement  (the  "Rights
Agreement") between  the Company and Wachovia Bank and Trust
Company, N.A., as Rights  Agent  (the  "Rights  Agent"),  as
amended on August 7, 1991 and August 3, 1994.

          Until   the  earlier  to  occur  of  (i)  10  days
following a public  announcement  that  a person or group of
affiliated   or   associated  persons  other  than   Ashland
Chemicals, Inc., First  Mississippi  Corporation,  or any of
their  affiliates  or  associates  have  acquired beneficial
ownership of 10% or more of the outstanding  Common  Shares,
(ii)  10  days  following a public announcement that Ashland
Chemicals, Inc.,  First  Mississippi  Corporation, or any of
their  affiliates  or  associates  has  acquired  beneficial
ownership of any Common Shares in addition to those owned by
such parties as of the adoption of the Rights Agreement (any
such person or group in foregoing clauses  (i)  or  (ii), an
"Acquiring  Person"),  or  (iii)  10  business days (or such
later date as may be determined by action  of  the  Board of
Directors  prior  to  such  time  as  any person or group of
affiliated  persons becomes an Acquiring  Person)  following
the commencement  of,  or  announcement  of  an intention to
make,  a tender offer or exchange offer the consummation  of
which would  result  in the beneficial ownership by a person
or group of 10% or more  of  the  outstanding  Common Shares
(the  earlier  of  such dates being called the "Distribution
Date"), the Rights will be evidenced, with respect to any of
the Common Share certificates  outstanding  as of the Record
Date, by such Common Share certificate with a  copy  of  the
Summary of Rights attached thereto.

          The  Rights  Agreement  provides  that,  until the
Distribution  Date  (or earlier redemption or expiration  of
the Rights), the Rights  will  be  transferred with and only
with  the  Common Shares.  Until the Distribution  Date  (or
earlier redemption  or expiration of the Rights), new Common
Share  certificates  issued   after  the  Record  Date  upon
transfer or new issuance of Common  Shares  will  contain  a
notation  incorporating  the  Rights Agreement by reference.
Until  the  Distribution  Date  (or  earlier  redemption  or
expiration of the Rights), the surrender for transfer of any
certificates for Common Shares outstanding  as of the Record
Date, even without such notation or a copy of the Summary of
Rights  being  attached  thereto,  will also constitute  the
transfer  of the Rights associated with  the  Common  Shares
represented  by  such  certificate.   As soon as practicable
following  the  Distribution  Date,  separate   certificates
evidencing the Rights ("Right Certificates") will  be mailed
to holders of record of the Common Shares as of the close of
business  on  the Distribution Date and such separate  Right
Certificates alone will evidence the Rights.

          The  Rights   are   not   exercisable   until  the
Distribution  Date.  The Rights will expire on November  15,
1997  (the  "Final   Expiration  Date"),  unless  the  Final
Expiration Date is extended or unless the Rights are earlier
redeemed or exchanged  by  the  Company,  in  each  case, as
described below.

          The  Purchase  Price  payable,  and the number  of
Preferred  Shares or other securities or property  issuable,
upon exercise  of  the Rights are subject to adjustment from
time to time to prevent dilution (i) in the event of a stock
dividend    on,   or   a   subdivision,    combination    or
reclassification  of,  the  Preferred  Shares, (ii) upon the
grant to holders of the Preferred Shares  of  certain rights
or warrants to subscribe for or purchase Preferred Shares at
a  price,  or  securities convertible into Preferred  Shares
with a conversion  price,  less than the then-current market
price of the Preferred Shares or (iii) upon the distribution
to  holders  of  the  Preferred   Shares   of  evidences  of
indebtedness  or  assets  (excluding  regular periodic  cash
dividends  paid  out  of  earnings or retained  earnings  or
dividends payable in Preferred  Shares)  or  of subscription
rights or warrants (other than those referred to above).

          The number of outstanding Rights and the number of
one  one-hundredths  of  a  Preferred  Share  issuable  upon
exercise of each Right are also subject to adjustment in the
event  of  a  stock  split of the Common Shares or  a  stock
dividend on the Common  Shares  payable  in Common Shares or
subdivisions, consolidations or combinations  of  the Common
Shares   occurring,   in   any   such  case,  prior  to  the
Distribution Date.

          Preferred Shares purchasable  upon exercise of the
Rights will not be redeemable.  Each Preferred Share will be
entitled  to  a  minimum  preferential  quarterly   dividend
payment of $1 per share but will be entitled to an aggregate
dividend  of  100  times  the  dividend  declared per Common
Share.   In  the  event of liquidation, the holders  of  the
Preferred Shares will  be entitled to a minimum preferential
liquidation payment of $100  per  share but will be entitled
to an aggregate payment of 100 times  the  payment  made per
Common  Share.   Each  Preferred  Share will have 100 votes,
voting  together with the Common Shares.   Finally,  in  the
event of  any  merger, consolidation or other transaction in
which Common Shares are exchanged, each Preferred Share will
be entitled to receive  100  times  the  amount received per
Common  Share.   These  rights  are protected  by  customary
antidilution provisions.

          Because  of the nature of  the  Preferred  Shares'
dividend, liquidation  and  voting  rights, the value of the
one one-hundredth interest in a Preferred  Share purchasable
upon exercise of each Right should approximate  the value of
one Common Share.

          In  the  event that the Company is acquired  in  a
merger or other business  combination  transaction or 50% or
more of its consolidated assets or earning  power  are sold,
proper provision will be made so that each holder of a Right
will thereafter have the right to receive, upon the exercise
thereof  at  the  then  current exercise price of the Right,
that  number of shares of  common  stock  of  the  acquiring
company  which  at  the time of such transaction will have a
market value of two times  the  exercise price of the Right.
In  the  event  that any person or group  of  affiliated  or
associated  persons  becomes  an  Acquiring  Person,  proper
provision shall  be  made  so  that  each holder of a Right,
other than Rights beneficially owned by the Acquiring Person
(which will thereafter be void), will  thereafter  have  the
right  to receive upon exercise that number of Common Shares
having a market value of two times the exercise price of the
Right.

          At  any time after any Person becomes an Acquiring
Person and prior  to the acquisition by such person or group
of 50% or more of the  outstanding  Common Shares, the Board
of Directors of the Company may exchange  the  Rights (other
than  Rights owned by such person or group which  will  have
become  void),  in whole or in part, at an exchange ratio of
one Common Share,  or one one-hundredth of a Preferred Share
(or  of  a share of a  class  or  series  of  the  Company's
preferred  stock  having  equivalent rights, preferences and
privileges), per Right (subject to adjustment).

          With  certain exceptions,  no  adjustment  in  the
Purchase Price will be required until cumulative adjustments
require an adjustment of at least 1% in such Purchase Price.
No fractional Preferred  Shares  will  be issued (other than
fractions which are integral multiples of  one one-hundredth
of  a  Preferred  Share, which may, at the election  of  the
Company, be evidenced  by  depositary  receipts) and in lieu
thereof,  an adjustment in cash will be made  based  on  the
market price of the Preferred Shares on the last trading day
prior to the date of exercise.

          At  any  time  prior  to  any  person  or group of
affiliated  or  associated  persons  becoming  an  Acquiring
Person, the Board of Directors of the Company may redeem the
Rights  in  whole,  but not in part, at a price of $.01  per
Right (the "Redemption Price"). The redemption of the Rights
may be made effective  at  such time on such basis with such
conditions as the Board of Directors  in its sole discretion
may  establish.   Immediately  upon  any redemption  of  the
Rights, the right to exercise the Rights  will terminate and
the only right of the holders of Rights will  be  to receive
the Redemption Price.

          The  terms  of  the  Rights may be amended by  the
Board of Directors of the company without the consent of the
holders of the Rights, except that  from and after such time
as any person or group of affiliated  or  associated persons
becomes an Acquiring Person no such amendment  may adversely
affect the interests of the holders of the Rights.

          Until a Right is exercised, the holder thereof, as
such,  will have no rights as a stockholder of the  Company,
including,  without  limitation,  the  right  to  vote or to
receive dividends.

          The  Rights  have  certain  anti-takeover effects.
The Rights will cause substantial dilution  to  a  person or
group  that  attempts  to  acquire the Company on terms  not
approved  by  the  Company's  Board   of  Directors,  except
pursuant to an offer conditioned on a substantial  number of
Rights being acquired.  The Rights should not interfere with
any  merger  or  other business combination approved by  the
Board of Directors  since  the Rights may be redeemed by the
Company at the Redemption Price  prior  to  the  time that a
person or group becomes an Acquiring Person.

          The Rights Agreement, dated as of November 5, 1990
between  the  Company  and  Wachovia Bank and Trust Company,
N.A., as Rights Agent, specifying  the  terms  of the Rights
and  including  the  form of the Certificate of Designation,
Preferences  and Rights  setting  forth  the  terms  of  the
Preferred Shares as an exhibit thereto and the form of press
release  announcing  the  declaration  of  the  Rights  were
attached as  exhibits to the Registrant's Form 8-A, which is
amended hereby,  and  are  incorporated herein by reference.
The foregoing description of  the Rights is qualified in its
entirety by reference to such exhibits.





                                                  Exhibit 5

                        THIRD AMENDMENT TO
                         RIGHTS AGREEMENT


     This Third Amendment to Rights Agreement by and between
Melamine   Chemicals,  Inc.,  a  Delaware  corporation  (the
"Company"),  and Wachovia Bank, N.A. (formerly Wachovia Bank
and Trust Company,  N.A.)  (the  "Rights  Agent") is entered
into as of October 9, 1997.


                       W I T N E S S E T H:

     WHEREAS, on November 5, 1990, the Board of Directors of
the Company authorized the issuance and declared  a dividend
of one right (a "Right") for each share of common stock, par
value $.01 per share, of the Company outstanding as  of  the
close  of  business  on  November 15,  1990, with each Right
representing  the  right to purchase 1/100  of  a  share  of
Series A Junior Participating  Preferred  Stock,  par  value
$1.00 per share, of the Company;

     WHEREAS,  the Board of Directors of the Company further
authorized the issuance  of  one  Right with respect to each
share  of  common  stock of the Company  that  shall  become
outstanding between  November  15,  1990 and the earliest of
the Distribution Date, the Redemption  Date  and  the  Final
Expiration Date, as defined in that certain Rights Agreement
(the  "Rights  Agreement"),  dated  as  of  November 5, 1990
between the Company and the Rights Agent;

     WHEREAS,  Section 7 of the Rights Agreement  originally
defined "Final Expiration Date" as the "close of business on
November 15, 1991;"

     WHEREAS, Section  27  of the Rights Agreement provides,
in part, that the Company and  the Rights Agent may, without
the approval of, or notice to, the  holders  of  the Rights,
amend  or  supplement  the  Rights  Agreement  to  make  any
provision  with respect to the Rights that the Company deems
necessary or desirable;

     WHEREAS,   pursuant   to   Section  27  of  the  Rights
Agreement, on August 7, 1991, the  Company  and  the  Rights
Agent  amended  Section  7 of the Rights Agreement to extend
the  Final Expiration Date  to  the  close  of  business  on
November 15, 1994;

     WHEREAS,   pursuant   to   Section  27  of  the  Rights
Agreement, on August 3, 1994, the  Company  and  the  Rights
Agent  amended  Section  7 of the Rights Agreement to extend
the  Final Expiration Date  to  the  close  of  business  on
November 15, 1997; and

     WHEREAS,   pursuant   to   Section  27  of  the  Rights
Agreement,  the  Company  and  the Rights  Agent  desire  to
further  amend  and modify the Rights  Agreement  to  extend
further  the effective  term  of  the  Rights  Agreement  by
defining the  Final  Expiration  Date  as  of  the  close of
business on November 15, 1998;

     NOW  THEREFORE, in consideration of the foregoing,  the
parties hereto agree as follows:

     1.   The  definition  of  Final  Expiration Date as set
forth  in  Section  7(a)(i)  of  the  Rights  Agreement,  as
amended,  is  hereby  amended  to  read in its  entirety  as
follows:

          "(i) the close of business  on  November  15,
     1998 (the "Final Expiration Date")"

     2.   Except  as expressly set forth herein, this  Third
Amendment to Rights  Agreement  shall  not be implication or
otherwise alter, modify, amend or in any  way  affect any of
the  terms, conditions, obligations, covenants or  agreement
contained  in  the  Rights Agreement, as heretofore amended,
all of which are ratified  and  affirmed in all respects and
shall continue in full force and effect.

     IN WITNESS WHEREAS, the parties hereto have caused this
Third Amendment to Rights Agreement  to be executed by their
respective proper and duly authorized  officers  as  of  the
date first above written.

ATTEST:                                 MELAMINE CHEMICALS, INC.



BY:  /s/ Wayne D. DeLeo                 BY:  /s/ Frederic R. Huber
     -------------------------               ---------------------
     Wayne D. DeLeo, Vice President          Frederic R. Huber
     and Chief Financial Officer             President


ATTEST:                                 WACHOVIA BANK,N.A.



BY:  /s/  Darrell V. Milton             BY:  /s/  Molly A. Long
     -------------------------               ---------------------------
Name:  Darrell V. Milton                Name:  Molly A. Long
Title:  Assistant Secretary             Title:  Senior Vice President






                                                Exhibit 6

                   FOURTH AMENDMENT TO
                    RIGHTS AGREEMENT


     AMENDMENT,  dated  and  effective  as  of October 9,
1997,  to  the Rights Agreement, dated as of November  5,
1990   (the   "Rights   Agreement"),   between   Melamine
Chemicals, Inc.,  a Delaware corporation (the "Company"),
and Wachovia Bank and  Trust  Company, N.A. (now Wachovia
Bank, N.A.) (the "Rights Agent"),  as  heretofore amended
by an Amendment to Rights Agreement, dated  as  of August
7,  1991,  between the Company and the Rights Agent  (the
"First  Amendment"),   a   Second   Amendment  to  Rights
Agreement,  dated  as  of  August  3, 1994,  between  the
Company  and  the Rights Agent (the "Second  Amendment"),
and a Third Amendment  to  Rights  Agreement, dated as of
October 9, 1997, between the Company and the Rights Agent
(the "Third Amendment"),

                     W I T N E S S E T H:

     WHEREAS, on November 5, 1990, the Board of Directors
of  the Company authorized the issuance  and  declared  a
dividend  of  one  right  (a  "Right")  for each share of
common  stock,  par value $.01 per share of  the  Company
outstanding as of  the  close of business on November 15,
1990, with each Right representing  the right to purchase
1/100  of  a  share  of  Series  A  Junior  Participating
Preferred  Stock,  par  value  $1.00  per  share, of  the
Company;

     WHEREAS,  the  Board  of  Directors  of the  Company
further authorized the issuance of one Right with respect
to each share of common stock of the Company  that  shall
become  outstanding  between  November  15,  1990 and the
earliest  of  the Distribution Date, the Redemption  Date
and the Final Expiration  Date,  as defined in the Rights
Agreement;

     WHEREAS,  Section  7  of  the  Rights  Agreement  as
heretofore amended defines Final Expiration  Date  as the
"close of business on November 15, 1998;"

     WHEREAS,   Section   27   of  the  Rights  Agreement
provides, in part, that the Company  and the Rights Agent
may, without the approval of, or notice  to,  the holders
of  the  Rights, amend or supplement the Rights Agreement
to make any provision with respect to the Rights that the
Company deems necessary or desirable; and

     WHEREAS,  the Company and the Rights Agent desire to
further amend and  modify the Rights Agreement in certain
respects.

     NOW THEREFORE,  in  consideration  of  the foregoing
premises  and  mutual agreements set forth in the  Rights
Agreement  as  heretofore   amended   and   this   Fourth
Amendment, the parties hereby agree as follows:

     1.   The Rights Agreement, as heretofore amended, is
hereby further modified and amended by deleting the first
sentence  of  paragraph (a) of Section 1 and substituting
therefor the following:

          (a)   "Acquiring  Person"  shall  mean any
     Person  (as  such  term is hereinafter defined)
     who or which, together  with all Affiliates and
     Associates  (as  such  terms   are  hereinafter
     defined)   of   such   Person,  shall  be   the
     Beneficial Owner (as such  term  is hereinafter
     defined) of 10% or more of the Common Shares of
     the  Company  then outstanding, but  shall  not
     include (i) the  Company,  (ii)  any Subsidiary
     (as  such term is hereinafter defined)  of  the
     Company, (iii) any employee benefit plan of the
     Company  or any Subsidiary of the Company, (iv)
     any  entity   holding   Common  Shares  for  or
     pursuant to the terms of  any  such  plan,  (v)
     Ashland  Chemical,  Inc.,  ChemFirst,  Inc., as
     successor to First Mississippi Corporation,  or
     any  Affiliate  or  Associate of either Ashland
     Chemical, Inc. or ChemFirst,  Inc. (each of the
     foregoing  in  this  clause  (v), an  "Exempted
     Person"),  unless  such Exempted  Person  shall
     acquire additional Common Shares after the date
     hereof, or (vi) Borden  Chemical,  Inc.  or its
     Subsidiaries,    Affiliates    or    Associates
     (hereinafter, collectively, "Borden").


     2.   The Rights Agreement, as heretofore amended, is
hereby   further  modified  and  amended  by  adding   an
additional  paragraph at the end of the definition of the
terms  "Beneficial   Owner"  and  "beneficially  own"  in
paragraph (c) of Section 1 reading as follows:

     Notwithstanding anything  in this definition of
     Beneficial  Owner and Beneficial  Ownership  to
     the contrary,  Borden shall not be deemed to be
     the Beneficial Owner  of,  nor  to beneficially
     own,  any of the Common Shares of  the  Company
     solely  by reason of the approval, execution or
     delivery  by any party thereto, or by reason of
     the amendment  or  consummation  of  any of the
     transactions  contemplated by (A) the Agreement
     and  Plan  of  Merger   by   and  among  Borden
     Chemical, Inc., MC Merger Corp.,  and  Melamine
     Chemicals,  Inc.  dated  and  effective  as  of
     October  9,  1997  (the "Merger Agreement"), or
     (B) the Tender Agreement  dated October 9, 1997
     by and among Borden Chemical,  Inc.,  MC Merger
     Corp.,   and   ChemFirst,   Inc.  (the  "Tender
     Agreement").

     3.   The Rights Agreement, as heretofore amended, is
hereby further modified and amended by deleting the first
sentence  of paragraph (a) of Section  3  of  the  Rights
Agreement and substituting therefor the following:

     (a)  Until  the  earlier  of  (i) the tenth day
     after the Shares Acquisition Date  or  (ii) the
     tenth  business day (or such later date as  may
     be  determined   by  action  of  the  Board  of
     Directors prior to  such  time  as  any  Person
     becomes an Acquiring Person) after the date  of
     the  commencement by any Person (other than (i)
     the  Company,   (ii)   any  Subsidiary  of  the
     Company, (iii) any employee benefit plan of the
     Company or of any Subsidiary  of  the  Company,
     (iv)  any  entity holding Common Shares for  or
     pursuant to  the  terms of any such plan or (v)
     Borden) of, or of the first public announcement
     of the intention of  any Person (other than (i)
     the  Company,  (ii)  any   Subsidiary   of  the
     Company, (iii) any employee benefit plan of the
     Company  or  of  any Subsidiary of the Company,
     (iv) any entity holding  Common  Shares  for or
     pursuant  to the terms of any such plan or  (v)
     Borden) to commence, a tender or exchange offer
     the consummation  of  which would result in any
     Person becoming the Beneficial  Owner of Common
     Shares  aggregating  10%  or more of  the  then
     outstanding Common Shares (including  any  such
     date  which is after the date of this Agreement
     and prior  to  the  issuance of the Rights; the
     earlier of such dates  being herein referred to
     as  the "Distribution Date"),  (x)  the  Rights
     will be evidenced (subject to the provisions of
     Section  3(b)  hereof)  by the certificates for
     Common Shares registered  in  the  names of the
     holders thereof (which certificates  shall also
     be deemed to be Right Certificates) and  not by
     separate  Right Certificates, and (y) the right
     to   receive   Right   Certificates   will   be
     transferable   only   in  connection  with  the
     transfer of Common Shares.

     4.   The Rights Agreement, as heretofore amended, is
hereby further modified and amended by deleting paragraph
(a) of Section 7 and substituting therefor the following:

          (a) The registered  holder  of  any  Right
     Certificate  may  exercise the Rights evidenced
     thereby (except as  otherwise  provided herein)
     in  whole  or  part  at  any  time  after   the
     Distribution  Date  upon surrender of the Right
     Certificate,  with  the  form  of  election  to
     purchase  on  the  reverse  side  thereof  duly
     executed, to the Rights  Agent at the principal
     office  of  the  Rights  Agent,  together  with
     payment of the Purchase Price for each one one-
     hundredth of a Preferred Share  as to which the
     Rights  are  exercised,  at  or  prior  to  the
     earliest  of  (i)  the  close  of  business  on
     November   15,   1998  (the  "Final  Expiration
     Date"), (ii) the time  at  which the Rights are
     redeemed as provided in Section 23  hereof (the
     "Redemption  Date"),  (iii) the  time at  which
     such  rights  are  exchanged  as  provided   in
     Section 24 hereof, or (iv) immediately prior to
     the acceptance for purchase of Common Shares by
     Borden  pursuant  to the Offer (as such term is
     defined in the Merger Agreement).

     5.   The Rights Agreement, as heretofore amended, is
hereby  further  amended  by  adding  the  following  new
Section 34 at the end:

     Section      34.        Borden     Transaction.
     Notwithstanding anything  in  this Agreement to
     the   contrary,   neither   (a) the   approval,
     execution,  delivery, amendment or consummation
     of any of the  transactions contemplated by the
     Merger Agreement  or  the  Tender  Agreement or
     (b) the  public  announcement  or making  of  a
     tender offer by Borden for Common Shares of the
     Company, or the acceptance for purchase of such
     shares  thereunder, shall cause (i)  Borden  to
     become  an   Acquiring  Person,  (ii) a  Shares
     Acquisition   Date   to   occur,   or   (iii) a
     Distribution Date  to  occur.  Any Distribution
     Date that might or could  otherwise occur under
     this  Agreement shall be indefinitely  deferred
     until such  time  as the Board of Directors may
     otherwise determine.

     6.   This Fourth Amendment  to  the Rights Agreement
shall be governed by and construed in accordance with the
internal laws of the State of Delaware.

     7.   This Fourth Amendment to the  Rights  Agreement
may be executed in any number of counterparts and each of
such  counterparts  shall  for all purposes be deemed  an
original,  and  all  such  counterparts   shall  together
constitute but one and the same instrument.

     8.   Except  as  expressly  set  forth herein,  this
Fourth  Amendment to the Rights Agreement  shall  not  by
implication  or  otherwise alter, modify, amend or in any
way affect any of  the  terms,  conditions,  obligations,
covenants   or   agreements   contained   in  the  Rights
Agreement,  as  heretofore  amended,  all  of  which  are
ratified and affirmed in all respects and shall  continue
in full force and effect.

     IN  WITNESS  WHEREAS, the parties hereto have caused
this Fourth Amendment  to  the  Rights  Agreement  to  be
executed  by  their respective proper and duly authorized
officers, as of the date first above written.

ATTEST:                                 MELAMINE CHEMICALS, INC.



By:  /s/ Wayne D. DeLeo                 By:  /s/ Frederic R. Huber
     -------------------------               --------------------------
     Wayne D. DeLeo, Vice President          Frederic R.Huber
     and Chief Financial Officer             President


ATTEST:                                 WACHOVIA BANK, N.A.



By:  /s/ Darrell V. Milton              By:  /s/ Molly A. Long
     ---------------------                   -----------------
Name:  Darrell V. Milton                Name:  Molly A. Long
Title:  Assistant Secretary             Title:  Senior Vice President





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission